APO Research
Talk to an analyst

APO RESEARCH · REPORT

Valsartan Capsules

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Valsartan Capsules Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

28 December 2025184 pages

Choose your research edition.

Industry ResearchValsartan Capsules Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Valsartan Capsules Industry Growth and Trends Forecast to 203290 pages · $3,450 USDMarket StructureGlobal Valsartan Capsules Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032184 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Valsartan Capsules Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Valsartan Capsules Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Valsartan Capsules market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Valsartan Capsules is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Valsartan Capsules is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Valsartan Capsules is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Valsartan Capsules is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Valsartan Capsules include Conquer, Dynemed, Mylan, Lepu Medical, Cisen Pharmaceutical, Torrent Pharmaceuticals, Teva Pharmaceutical Industries, Sun Pharmaceutical and Novartis, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Valsartan Capsules market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Valsartan Capsules and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Valsartan Capsules sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Valsartan Capsules market size, projected growth trends, production technologies, key applications, and end-use industries.

Valsartan Capsules Segment by Company

Conquer

Dynemed

Mylan

Lepu Medical

Cisen Pharmaceutical

Torrent Pharmaceuticals

Teva Pharmaceutical Industries

Sun Pharmaceutical

Novartis

Valsartan Capsules Segment by Type

160 Mg

40 Mg

80 Mg

Others

Valsartan Capsules Segment by Application

Treatment of Hypertension

Treatment of Heart Disease

Others

Valsartan Capsules Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Valsartan Capsules market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Valsartan Capsules and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Valsartan Capsules.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Valsartan Capsules market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Valsartan Capsules manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Valsartan Capsules in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Valsartan Capsules in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Valsartan Capsules Industry Trends Table 2. Valsartan Capsules Industry Drivers Table 3. Valsartan Capsules Industry Opportunities and Challenges Table 4. Valsartan Capsules Industry Restraints Table 5. Global Valsartan Capsules Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Valsartan Capsules Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Valsartan Capsules Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Valsartan Capsules Sales Market Share by Manufacturers Table 9. Global Valsartan Capsules Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Valsartan Capsules Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Valsartan Capsules Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Valsartan Capsules Manufacturers, Product Type & Application Table 13. Global Valsartan Capsules Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Valsartan Capsules by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of 160 Mg Table 17. Major Manufacturers of 40 Mg Table 18. Major Manufacturers of 80 Mg Table 19. Major Manufacturers of Others Table 20. Global Valsartan Capsules Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 21. Global Valsartan Capsules Sales by Type (2021-2026) & (K Units) Table 22. Global Valsartan Capsules Sales by Type (2027-2032) & (K Units) Table 23. Global Valsartan Capsules Sales Market Share by Type (2021-2026) Table 24. Global Valsartan Capsules Sales Market Share by Type (2027-2032) Table 25. Global Valsartan Capsules Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 26. Global Valsartan Capsules Revenue by Type (2021-2026) & (K Units) Table 27. Global Valsartan Capsules Revenue by Type (2027-2032) & (K Units) Table 28. Global Valsartan Capsules Revenue Market Share by Type (2021-2026) Table 29. Global Valsartan Capsules Revenue Market Share by Type (2027-2032) Table 30. Major Manufacturers of Treatment of Hypertension Table 31. Major Manufacturers of Treatment of Heart Disease Table 32. Major Manufacturers of Others Table 33. Global Valsartan Capsules Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 34. Global Valsartan Capsules Sales by Application (2021-2026) & (K Units) Table 35. Global Valsartan Capsules Sales by Application (2027-2032) & (K Units) Table 36. Global Valsartan Capsules Sales Market Share by Application (2021-2026) Table 37. Global Valsartan Capsules Sales Market Share by Application (2027-2032) Table 38. Global Valsartan Capsules Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 39. Global Valsartan Capsules Revenue by Application (2021-2026) & (K Units) Table 40. Global Valsartan Capsules Revenue by Application (2027-2032) & (K Units) Table 41. Global Valsartan Capsules Revenue Market Share by Application (2021-2026) Table 42. Global Valsartan Capsules Revenue Market Share by Application (2027-2032) Table 43. Global Valsartan Capsules Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 44. Global Valsartan Capsules Sales by Region (2021-2026) & (K Units) Table 45. Global Valsartan Capsules Sales Market Share by Region (2021-2026) Table 46. Global Valsartan Capsules Sales Forecasted by Region (2027-2032) & (K Units) Table 47. Global Valsartan Capsules Sales Forecasted Market Share by Region (2027-2032) Table 48. North America Valsartan Capsules Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 49. North America Valsartan Capsules Sales by Country (2021-2026) & (K Units) Table 50. North America Valsartan Capsules Sales by Country (2027-2032) & (K Units) Table 51. Europe Valsartan Capsules Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 52. Europe Valsartan Capsules Sales by Country (2021-2026) & (K Units) Table 53. Europe Valsartan Capsules Sales by Country (2027-2032) & (K Units) Table 54. Asia Pacific Valsartan Capsules Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. Asia Pacific Valsartan Capsules Sales by Country (2021-2026) & (K Units) Table 56. Asia Pacific Valsartan Capsules Sales by Country (2027-2032) & (K Units) Table 57. South America, Middle East and Africa Valsartan Capsules Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 58. South America, Middle East and Africa Valsartan Capsules Sales by Country (2021-2026) & (K Units) Table 59. South America, Middle East and Africa Valsartan Capsules Sales by Country (2027-2032) & (K Units) Table 60. Global Valsartan Capsules Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 61. Global Valsartan Capsules Revenue by Region (2021-2026) & (US$ Million) Table 62. Global Valsartan Capsules Revenue by Region (2027-2032) & (US$ Million) Table 63. Global Valsartan Capsules Revenue Market Share by Region (2021-2026) Table 64. Global Valsartan Capsules Revenue Market Share by Region (2027-2032) Table 65. Conquer Company Information Table 66. Conquer Business Overview Table 67. Conquer Valsartan Capsules Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. Conquer Valsartan Capsules Product Portfolio Table 69. Conquer Recent Development Table 70. Dynemed Company Information Table 71. Dynemed Business Overview Table 72. Dynemed Valsartan Capsules Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. Dynemed Valsartan Capsules Product Portfolio Table 74. Dynemed Recent Development Table 75. Mylan Company Information Table 76. Mylan Business Overview Table 77. Mylan Valsartan Capsules Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. Mylan Valsartan Capsules Product Portfolio Table 79. Mylan Recent Development Table 80. Lepu Medical Company Information Table 81. Lepu Medical Business Overview Table 82. Lepu Medical Valsartan Capsules Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. Lepu Medical Valsartan Capsules Product Portfolio Table 84. Lepu Medical Recent Development Table 85. Cisen Pharmaceutical Company Information Table 86. Cisen Pharmaceutical Business Overview Table 87. Cisen Pharmaceutical Valsartan Capsules Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. Cisen Pharmaceutical Valsartan Capsules Product Portfolio Table 89. Cisen Pharmaceutical Recent Development Table 90. Torrent Pharmaceuticals Company Information Table 91. Torrent Pharmaceuticals Business Overview Table 92. Torrent Pharmaceuticals Valsartan Capsules Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 93. Torrent Pharmaceuticals Valsartan Capsules Product Portfolio Table 94. Torrent Pharmaceuticals Recent Development Table 95. Teva Pharmaceutical Industries Company Information Table 96. Teva Pharmaceutical Industries Business Overview Table 97. Teva Pharmaceutical Industries Valsartan Capsules Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 98. Teva Pharmaceutical Industries Valsartan Capsules Product Portfolio Table 99. Teva Pharmaceutical Industries Recent Development Table 100. Sun Pharmaceutical Company Information Table 101. Sun Pharmaceutical Business Overview Table 102. Sun Pharmaceutical Valsartan Capsules Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 103. Sun Pharmaceutical Valsartan Capsules Product Portfolio Table 104. Sun Pharmaceutical Recent Development Table 105. Novartis Company Information Table 106. Novartis Business Overview Table 107. Novartis Valsartan Capsules Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 108. Novartis Valsartan Capsules Product Portfolio Table 109. Novartis Recent Development Table 110. Key Raw Materials Table 111. Raw Materials Key Suppliers Table 112. Valsartan Capsules Distributors List Table 113. Valsartan Capsules Customers List Table 114. Research Programs/Design for This Report Table 115. Authors List of This Report Table 116. Secondary Sources Table 117. Primary Sources List of Figures Figure 1. Valsartan Capsules Product Image Figure 2. Global Valsartan Capsules Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Valsartan Capsules Market Size (2021-2032) & (US$ Million) Figure 4. Global Valsartan Capsules Sales (2021-2032) & (K Units) Figure 5. Global Valsartan Capsules Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Valsartan Capsules Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. 160 Mg Image Figure 9. 40 Mg Image Figure 10. 80 Mg Image Figure 11. Others Image Figure 12. Global Valsartan Capsules Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 13. Global Valsartan Capsules Sales Market Share 2021 VS 2025 VS 2032 Figure 14. Global Valsartan Capsules Sales Market Share by Type (2021-2032) Figure 15. Global Valsartan Capsules Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 16. Global Valsartan Capsules Revenue Market Share 2021 VS 2025 VS 2032 Figure 17. Global Valsartan Capsules Revenue Market Share by Type (2021-2032) Figure 18. Treatment of Hypertension Image Figure 19. Treatment of Heart Disease Image Figure 20. Others Image Figure 21. Global Valsartan Capsules Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 22. Global Valsartan Capsules Sales Market Share 2021 VS 2025 VS 2032 Figure 23. Global Valsartan Capsules Sales Market Share by Application (2021-2032) Figure 24. Global Valsartan Capsules Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 25. Global Valsartan Capsules Revenue Market Share 2021 VS 2025 VS 2032 Figure 26. Global Valsartan Capsules Revenue Market Share by Application (2021-2032) Figure 27. North America Valsartan Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 28. North America Valsartan Capsules Sales Market Share by Country (2021-2032) Figure 29. U.S. Valsartan Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Canada Valsartan Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Mexico Valsartan Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 32. Europe Valsartan Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 33. Europe Valsartan Capsules Sales Market Share by Country (2021-2032) Figure 34. Germany Valsartan Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 35. France Valsartan Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 36. U.K. Valsartan Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Italy Valsartan Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Netherlands Valsartan Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 39. Asia Pacific Valsartan Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Asia Pacific Valsartan Capsules Sales Market Share by Country (2021-2032) Figure 41. China Valsartan Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Japan Valsartan Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 43. South Korea Valsartan Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 44. Southeast Asia Valsartan Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 45. India Valsartan Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 46. Australia Valsartan Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 47. South America, Middle East and Africa Valsartan Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 48. South America, Middle East and Africa Valsartan Capsules Sales Market Share by Country (2021-2032) Figure 49. Brazil Valsartan Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 50. South Africa Valsartan Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Saudi Arabia Valsartan Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 52. Turkey Valsartan Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Argentina Valsartan Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 54. UAE Valsartan Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Egypt Valsartan Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 56. Chile Valsartan Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 57. Global Valsartan Capsules Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Global Valsartan Capsules Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 59. North America Valsartan Capsules Revenue (2021-2032) & (US$ Million) Figure 60. North America Valsartan Capsules Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Europe Valsartan Capsules Revenue (2021-2032) & (US$ Million) Figure 62. Europe Valsartan Capsules Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. Asia-Pacific Valsartan Capsules Revenue (2021-2032) & (US$ Million) Figure 64. Asia-Pacific Valsartan Capsules Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. South America, Middle East and Africa Valsartan Capsules Revenue (2021-2032) & (US$ Million) Figure 66. South America, Middle East and Africa Valsartan Capsules Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 67. Valsartan Capsules Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Valsartan Capsules Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • 160 Mg
  • 40 Mg
  • 80 Mg
  • Others
Applications
  • Treatment of Hypertension
  • Treatment of Heart Disease
  • Others
Companies covered
  • Conquer
  • Dynemed
  • Mylan
  • Lepu Medical
  • Cisen Pharmaceutical
  • Torrent Pharmaceuticals
  • Teva Pharmaceutical Industries
  • Sun Pharmaceutical
  • Novartis

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Valsartan Capsules Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Valsartan Capsules Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Valsartan Capsules Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Valsartan Capsules Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Valsartan Capsules Market Dynamics
  1. 2.1 Valsartan Capsules Industry Trends
  2. 2.2 Valsartan Capsules Industry Drivers
  3. 2.3 Valsartan Capsules Industry Opportunities and Challenges
  4. 2.4 Valsartan Capsules Industry Restraints
3 Valsartan Capsules Market by Manufacturers
  1. 3.1 Global Valsartan Capsules Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Valsartan Capsules Sales by Manufacturers (2021-2026)
  3. 3.3 Global Valsartan Capsules Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Valsartan Capsules Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Valsartan Capsules Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Valsartan Capsules Manufacturers, Product Type & Application
  7. 3.7 Global Valsartan Capsules Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Valsartan Capsules Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Valsartan Capsules Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Valsartan Capsules Tier 1, Tier 2, and Tier 3
4 Valsartan Capsules Market by Type
  1. 4.1 Valsartan Capsules Type Introduction
  2. 4.1.1 160 Mg
  3. 4.1.2 40 Mg
  4. 4.1.3 80 Mg
  5. 4.1.4 Others
  6. 4.2 Global Valsartan Capsules Sales by Type
  7. 4.2.1 Global Valsartan Capsules Sales by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Valsartan Capsules Sales by Type (2021-2032)
  9. 4.2.3 Global Valsartan Capsules Sales Market Share by Type (2021-2032)
  10. 4.3 Global Valsartan Capsules Revenue by Type
  11. 4.3.1 Global Valsartan Capsules Revenue by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Valsartan Capsules Revenue by Type (2021-2032)
  13. 4.3.3 Global Valsartan Capsules Revenue Market Share by Type (2021-2032)
5 Valsartan Capsules Market by Application
  1. 5.1 Valsartan Capsules Application Introduction
  2. 5.1.1 Treatment of Hypertension
  3. 5.1.2 Treatment of Heart Disease
  4. 5.1.3 Others
  5. 5.2 Global Valsartan Capsules Sales by Application
  6. 5.2.1 Global Valsartan Capsules Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Valsartan Capsules Sales by Application (2021-2032)
  8. 5.2.3 Global Valsartan Capsules Sales Market Share by Application (2021-2032)
  9. 5.3 Global Valsartan Capsules Revenue by Application
  10. 5.3.1 Global Valsartan Capsules Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Valsartan Capsules Revenue by Application (2021-2032)
  12. 5.3.3 Global Valsartan Capsules Revenue Market Share by Application (2021-2032)
6 Global Valsartan Capsules Sales by Region
  1. 6.1 Global Valsartan Capsules Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Valsartan Capsules Sales by Region (2021-2032)
  3. 6.2.1 Global Valsartan Capsules Sales by Region (2021-2026)
  4. 6.2.2 Global Valsartan Capsules Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Valsartan Capsules Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Valsartan Capsules Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Valsartan Capsules Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Valsartan Capsules Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Valsartan Capsules Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Valsartan Capsules Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Valsartan Capsules Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Valsartan Capsules Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Valsartan Capsules Revenue by Region
  1. 7.1 Global Valsartan Capsules Revenue by Region
  2. 7.1.1 Global Valsartan Capsules Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Valsartan Capsules Revenue by Region (2021-2026)
  4. 7.1.3 Global Valsartan Capsules Revenue by Region (2027-2032)
  5. 7.1.4 Global Valsartan Capsules Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Valsartan Capsules Revenue (2021-2032)
  8. 7.2.2 North America Valsartan Capsules Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Valsartan Capsules Revenue (2021-2032)
  11. 7.3.2 Europe Valsartan Capsules Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Valsartan Capsules Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Valsartan Capsules Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Valsartan Capsules Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Valsartan Capsules Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Conquer
  2. 8.1.1 Conquer Company Information
  3. 8.1.2 Conquer Business Overview
  4. 8.1.3 Conquer Valsartan Capsules Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Conquer Valsartan Capsules Product Portfolio
  6. 8.1.5 Conquer Recent Developments
  7. 8.2 Dynemed
  8. 8.2.1 Dynemed Company Information
  9. 8.2.2 Dynemed Business Overview
  10. 8.2.3 Dynemed Valsartan Capsules Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Dynemed Valsartan Capsules Product Portfolio
  12. 8.2.5 Dynemed Recent Developments
  13. 8.3 Mylan
  14. 8.3.1 Mylan Company Information
  15. 8.3.2 Mylan Business Overview
  16. 8.3.3 Mylan Valsartan Capsules Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Mylan Valsartan Capsules Product Portfolio
  18. 8.3.5 Mylan Recent Developments
  19. 8.4 Lepu Medical
  20. 8.4.1 Lepu Medical Company Information
  21. 8.4.2 Lepu Medical Business Overview
  22. 8.4.3 Lepu Medical Valsartan Capsules Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Lepu Medical Valsartan Capsules Product Portfolio
  24. 8.4.5 Lepu Medical Recent Developments
  25. 8.5 Cisen Pharmaceutical
  26. 8.5.1 Cisen Pharmaceutical Company Information
  27. 8.5.2 Cisen Pharmaceutical Business Overview
  28. 8.5.3 Cisen Pharmaceutical Valsartan Capsules Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Cisen Pharmaceutical Valsartan Capsules Product Portfolio
  30. 8.5.5 Cisen Pharmaceutical Recent Developments
  31. 8.6 Torrent Pharmaceuticals
  32. 8.6.1 Torrent Pharmaceuticals Company Information
  33. 8.6.2 Torrent Pharmaceuticals Business Overview
  34. 8.6.3 Torrent Pharmaceuticals Valsartan Capsules Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Torrent Pharmaceuticals Valsartan Capsules Product Portfolio
  36. 8.6.5 Torrent Pharmaceuticals Recent Developments
  37. 8.7 Teva Pharmaceutical Industries
  38. 8.7.1 Teva Pharmaceutical Industries Company Information
  39. 8.7.2 Teva Pharmaceutical Industries Business Overview
  40. 8.7.3 Teva Pharmaceutical Industries Valsartan Capsules Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Teva Pharmaceutical Industries Valsartan Capsules Product Portfolio
  42. 8.7.5 Teva Pharmaceutical Industries Recent Developments
  43. 8.8 Sun Pharmaceutical
  44. 8.8.1 Sun Pharmaceutical Company Information
  45. 8.8.2 Sun Pharmaceutical Business Overview
  46. 8.8.3 Sun Pharmaceutical Valsartan Capsules Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Sun Pharmaceutical Valsartan Capsules Product Portfolio
  48. 8.8.5 Sun Pharmaceutical Recent Developments
  49. 8.9 Novartis
  50. 8.9.1 Novartis Company Information
  51. 8.9.2 Novartis Business Overview
  52. 8.9.3 Novartis Valsartan Capsules Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Novartis Valsartan Capsules Product Portfolio
  54. 8.9.5 Novartis Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Valsartan Capsules Value Chain Analysis
  2. 9.1.1 Valsartan Capsules Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Valsartan Capsules Production Mode & Process
  6. 9.2 Valsartan Capsules Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Valsartan Capsules Distributors
  9. 9.2.3 Valsartan Capsules Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst